Skip to content

Clinical trials

Phase 3 Neurologic Manifestations trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Phase: Phase 3 Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20061
20071
20081
20101
20142
20151
20162
20171
20221
20232
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed26
Active, not recruiting4
Recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Center for Research Resources (NCRR)9
National Institute of Neurological Disorders and Stroke (NINDS)5
Auspex Pharmaceuticals, Inc.2
Taysha Gene Therapies, Inc.2
Auris Medical, Inc.1
Bayer1
Eli Lilly and Company1
Ethicon, Inc.1
Ipsen1
Laboratoires Thea1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations34
Mental Disorders16
Rare Diseases14
Nervous System Diseases9
Pain5
Central Nervous System Diseases4
Intellectual Disability4
Pathologic Processes4
Genetic Diseases, X-Linked3
Multiple Sclerosis3

Trials

Showing 76 to 34 of 34. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.